A novel Hepatitis B virus genotype in Indigenous Australians: impact on vaccine efficacy and clinical outcomes

我们最近在北领地（NT）土著社区发现了一种新型乙型肝炎病毒（HBV）基因型（C4）。与此同时，流行病学研究表明，HBV疫苗可能效果不佳，在这些社区中，HBV引起的肝癌发病率很高。我们的项目将确定HBV/C4是否与疫苗反应不良和肝脏疾病加速有关，这将对HBV疫苗策略和HBV/C4感染的临床管理产生影响。

We have recently identified a novel Hepatitis B virus (HBV) genotype (C4) circulating in Northern Territory (NT) Indigenous communities. Concurrently, epidemiological studies suggest that the HBV vaccine may not be working well and that there are high rates of liver cancer due to HBV in these communities. Our project will determine if HBV/C4 is linked to poor vaccine responses and accelerated liver disease, with implications for HBV vaccine strategy and clinical management of HBV/C4 infections.